Evidence map›Paper›PMID 40233929›Full record

ReviewChemical research in toxicology2025

Sugars in Tobacco Products: Toxicity Research and Implications for Tobacco Product Regulation.

Irina Stepanov, Micah Berman, Marielle C Brinkman, Alex Carll, Vernat Exil, Eleanore G Hansen, Ahmad El Hellani, Sairam V Jabba, Nada O F Kassem, Mary Rezk-Hanna and 2 more

Abstract readReview
In one paragraph

Review in Chemical research in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Stable isotope labeling reveals that sugars are direct precursors to several toxicants and flavorings in cigarette smoke.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Biological and Behavioral Responses ofInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Irina StepanovInstitute for Global Cancer Prevention Research, Masonic Cancer Center, University of Minnesota, Room 2-140, 2231 Sixth Street Southeast, Minneapolis, Minnesota 55455, United States.ORCID 0000-0001-5140-8944
Micah BermanCollege of Public Health and Moritz College of Law, The Ohio State University, 1841 Neil Avenue, Columbus, Ohio 43210, United States.
Marielle C BrinkmanDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio 43210, United States.ORCID 0000-0002-4315-649X
Alex CarllUniversity of Louisville School of Medicine, Louisville, Kentucky 40204, United States.ORCID 0000-0003-1832-3070
Vernat ExilDepartment of Pediatrics, Saint Louis University, 1465 South Grand Boulevard, Suite 5718, St. Louis, Missouri 63104, United States.
Eleanore G HansenDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID 0000-0002-6606-2912
Ahmad El HellaniCenter for Tobacco Research, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43214, United States.
Sairam V JabbaCenter for Translational Pain Medicine (CTPM), Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina 27710, United States.
Nada O F KassemHealth Promotion and Behavioral Science, San Diego State University, San Diego, California 92182, United States.ORCID 0000-0002-5403-7234
Mary Rezk-HannaSchool of Nursing, University of California, Los Angeles, Los Angeles, California 90095, United States.
Reinskje TalhoutCentre for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, Netherlands.ORCID 0000-0002-5310-9064
Andrea M StroupWestat, 1600 Research Boulevard, Rockville, Maryland 20850, United States.ORCID 0000-0003-2895-460X

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI LISA M FUCITO · 2018 to 2026
$41.6M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Andrea M Stroup · 2018 to 2026
$28.1M
Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3U54DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI FAGAN, PEBBLES · 2018 to 2022
$20.8M
The Ohio State University Tobacco Center of Regulatory Science (OSU-TCORS)U54CA287392 · NCI · OHIO STATE UNIVERSITY · PI Peter G. Shields, Theodore Lee Wagener · 2023 to 2026
$19.5M
Waterpipe tobacco additives and their effect on human puffing behavior, toxicant exposures, pulmonary function, and appealR01CA255563 · NCI · OHIO STATE UNIVERSITY · PI BRINKMAN, MARIELLE CAVANAUGH, WAGENER, THEODORE LEE · 2020 to 2022
$1.3M
Nicotine flux, a potentially powerful tool for regulating nicotine delivery from electronic cigarettes: significance of nicotine flux to the rate of nicotine delivery and subjective effectsR01DA052565 · NIDA · AMERICAN UNIVERSITY OF BEIRUT · PI EL HELLANI, AHMAD, TALIH, SOHA · 2022 to 2024
$1.3M
Impact of sugars on tobacco product toxicity and abuse liabilityR01DA051005 · NIDA · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K, STEPANOV, IRINA · 2020 to 2022
$1.3M
Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product CategoryR56DA055996 · NIDA · DUKE UNIVERSITY · PI JORDT, SVEN-ERIC · 2022 to 2022
$417k
NCI NIH HHS R01 CA255563NCI NIH HHS U54 CA287392NIDA NIH HHS R01 DA051005NIDA NIH HHS R01 DA052565NIDA NIH HHS R56 DA055996NIDA NIH HHS U54 DA036105NIDA NIH HHS U54 DA036151NIDA NIH HHS U54 DA046060
6 · The paper itself

Abstract

Sugars are naturally present in tobacco plants and are introduced as additives during the manufacturing of various tobacco- and nicotine-containing products. Product palatability and appeal are the primary reasons for manufacturers' attention to the sugar content in tobacco and nicotine products. However, because of the complex chemistry of sugars and their thermal decomposition, these versatile constituents are also contributing to the toxicity profile of tobacco and nicotine products. Using published empirical data, this non-systematic review summarizes the state of knowledge on the toxicologically relevant chemical transformations of sugars and artificial sweeteners in tobacco and nicotine products, including waterpipe tobacco, combustible and electronic cigarettes, heated tobacco products, and smokeless tobacco, and available research on the associated health effects of sugar-derived toxicants. Implications of sugar and sweetener content for abuse liability of various tobacco products are also discussed. Based on the findings of this review, research gaps are identified and policy recommendations are made for regulating sugars and artificial sweeteners in tobacco and nicotine products, including adding sugars and artificial sweeteners to the list of harmful and potentially harmful constituents (HPHCs).

Indexed as

SugarsSweetening AgentsTobacco ProductsAnimalsHumansSugarsSweetening Agents

Identifiers

PMID40233929
PMCPMC12093378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.